Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.
about
Claims Data Analysis of Tumor Necrosis Factor Inhibitor Treatment Dosing Among Patients with Rheumatoid Arthritis: A Systematic Review of MethodsComparative effectiveness research with administrative health data in rheumatoid arthritis.Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis.Application of a validated algorithm to estimate the effectiveness and cost of biologics for rheumatoid arthritis in the US pharmacy benefit manager context.Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort StudyCost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators.Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis.Treatment effectiveness and treatment patterns among rheumatoid arthritis patients after switching from a tumor necrosis factor inhibitor to another medication.Refining a Claims-based Algorithm to Estimate Biologic Medication Effectiveness and Cost per Effectively-treated Patient with Rheumatoid Arthritis.Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study.Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years.Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.
P2860
Q28069373-C26F4DE8-3599-4598-8167-0AB3E5798712Q31077662-106AB9C5-6C56-44D4-84D4-2352CED7A3C0Q33691553-EA5467CE-1950-4B92-960A-000525E0924DQ35617540-16992729-FA3A-4585-8DC1-B3F85538A676Q37452967-9F1BFEBE-B2C1-45B5-B356-A4BEE1D4A3D8Q38907286-8649CDF7-DC1D-44BC-9373-2C2391AF54FEQ39068415-25E5D731-B032-4FA4-8B96-157B75EAB90AQ42356300-2A739224-F6F9-43DE-8A88-5D85236D5D65Q46043250-B8F567E6-CA23-4E05-A883-E915957C07DBQ47970691-9F299A04-1781-4403-AA74-F542FD235735Q48520042-834FFAC8-3860-41CD-B608-608EB9DA7419Q52642347-250EC83F-B303-4355-BC83-D02F3C3DD421
P2860
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Estimating effectiveness and c ...... o commercial insurance claims.
@en
Estimating effectiveness and c ...... o commercial insurance claims.
@nl
type
label
Estimating effectiveness and c ...... o commercial insurance claims.
@en
Estimating effectiveness and c ...... o commercial insurance claims.
@nl
prefLabel
Estimating effectiveness and c ...... o commercial insurance claims.
@en
Estimating effectiveness and c ...... o commercial insurance claims.
@nl
P2093
P1476
Estimating effectiveness and c ...... o commercial insurance claims.
@en
P2093
Caroleen Quach
David H Collier
David J Harrison
George J Joseph
Huifeng Yun
Jason Yeaw
Jeffrey R Curtis
Jonathan R Korn
Vernon F Schabert
P304
P356
10.1016/J.CLINTHERA.2014.05.062
P577
2014-07-08T00:00:00Z